Mark B. Headley

5.1k total citations · 3 hit papers
32 papers, 3.7k citations indexed

About

Mark B. Headley is a scholar working on Immunology, Molecular Biology and Dermatology. According to data from OpenAlex, Mark B. Headley has authored 32 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Dermatology. Recurrent topics in Mark B. Headley's work include Dermatology and Skin Diseases (9 papers), Asthma and respiratory diseases (9 papers) and Allergic Rhinitis and Sensitization (6 papers). Mark B. Headley is often cited by papers focused on Dermatology and Skin Diseases (9 papers), Asthma and respiratory diseases (9 papers) and Allergic Rhinitis and Sensitization (6 papers). Mark B. Headley collaborates with scholars based in United States, United Kingdom and Japan. Mark B. Headley's co-authors include Matthew F. Krummel, Edward W. Roberts, Mark R. Looney, Steven F. Ziegler, Guadalupe Ortiz-Muñoz, Beñat Mallavia, Dusan Bogunovic, Tsuneyasu Kaisho, Denise M. Wolf and Nina Bhardwaj and has published in prestigious journals such as Nature, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Mark B. Headley

29 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors

2017 767 citations Emma Lefrançais, Guadalupe Ortiz-Muñoz et al. Nature profile →
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma

2016 729 citations Mark B. Headley, Matthew F. Krummel et al. profile →
TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation

2011 411 citations Mark C. Siracusa, Steven A. Saenz et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark B. Headley United States	20	1.9k	1.1k	698	637	466	32	3.7k
Bruno Azzarone France	37	2.0k 1.0×	1.0k 0.9×	1.1k 1.6×	422 0.7×	215 0.5×	132	4.1k
Shingo Nakayamada Japan	42	2.8k 1.5×	1.1k 1.0×	1.3k 1.8×	313 0.5×	168 0.4×	219	6.3k
Michael V. Volin United States	39	1.6k 0.9×	1.4k 1.3×	1.7k 2.4×	211 0.3×	497 1.1×	69	4.9k
Ola Winqvist Sweden	40	2.1k 1.1×	853 0.8×	932 1.3×	408 0.6×	276 0.6×	128	4.6k
Ayumi Yoshizaki Japan	34	2.2k 1.1×	919 0.8×	962 1.4×	212 0.3×	157 0.3×	192	4.8k
Matthew A. Sleeman United States	33	1.5k 0.8×	473 0.4×	853 1.2×	1.0k 1.6×	553 1.2×	82	3.8k
Birgitta Sander Sweden	37	1.4k 0.8×	1.3k 1.1×	1.0k 1.5×	213 0.3×	175 0.4×	141	4.4k
Nobuo Kanazawa Japan	27	1.6k 0.8×	559 0.5×	1.1k 1.6×	473 0.7×	151 0.3×	131	3.5k
Femke van Wijk Netherlands	33	1.5k 0.8×	420 0.4×	589 0.8×	366 0.6×	622 1.3×	113	3.2k
Claudia Wickenhauser Germany	37	1.1k 0.6×	1.1k 1.0×	1.4k 2.0×	173 0.3×	136 0.3×	199	4.3k

Countries citing papers authored by Mark B. Headley

Since Specialization

Citations

This map shows the geographic impact of Mark B. Headley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Headley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Headley more than expected).

Fields of papers citing papers by Mark B. Headley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Headley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Headley. The network helps show where Mark B. Headley may publish in the future.

Co-authorship network of co-authors of Mark B. Headley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Headley. A scholar is included among the top collaborators of Mark B. Headley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Headley. Mark B. Headley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hagan, Cassidy E., et al.. (2025). Apoptotic cells promote circulating tumor cell survival and metastasis. Communications Biology. 8(1). 1121–1121. 1 indexed citations

Rominger, Marga B., Saksham Gupta, Sitapriya Moorthi, et al.. (2025). Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state. Cell Reports. 44(10). 116185–116185.

Kersten, Kelly, Ran You, Kevin M. Tharp, et al.. (2023). Uptake of tumor-derived microparticles induces metabolic reprogramming of macrophages in the early metastatic lung. Cell Reports. 42(6). 112582–112582. 14 indexed citations

Becht, Étienne, Charles‐Antoine Dutertre, Peter A. Morawski, et al.. (2021). High-throughput single-cell quantification of hundreds of proteins using conventional flow cytometry and machine learning. Science Advances. 7(39). eabg0505–eabg0505. 40 indexed citations

Freedman, Tanya S., Mark B. Headley, Nina K. Serwas, et al.. (2020). Lessons of COVID-19: A roadmap for post-pandemic science. The Journal of Experimental Medicine. 217(9). 6 indexed citations

Puttur, Franz, Laura Denney, Lisa G. Gregory, et al.. (2019). Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans. Science Immunology. 4(36). 97 indexed citations

Owyong, Mark, Jonathan Chou, Renske J.E. van den Bijgaart, et al.. (2019). MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy. Life Science Alliance. 2(6). e201800226–e201800226. 78 indexed citations

Boussommier-Calleja, Alexandra, et al.. (2018). The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model. Biomaterials. 198. 180–193. 123 indexed citations

Looney, Mark R. & Mark B. Headley. (2018). Live imaging of the pulmonary immune environment. Cellular Immunology. 350. 103862–103862. 9 indexed citations

10.

Lefrançais, Emma, Guadalupe Ortiz-Muñoz, Axelle Caudrillier, et al.. (2017). The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 544(7648). 105–109. 767 indexed citations breakdown →

11.

Ortiz-Muñoz, Guadalupe, Beñat Mallavia, Adriaan D. Bins, et al.. (2014). Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood. 124(17). 2625–2634. 156 indexed citations

12.

Headley, Mark B., et al.. (2014). The spatiotemporal cellular dynamics of lung immunity. Trends in Immunology. 35(8). 379–386. 19 indexed citations

13.

Han, Heejae, Weidong Xu, Mark B. Headley, et al.. (2012). Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunology. 5(3). 342–351. 82 indexed citations

14.

Han, Heejae, Weidong Xu, Mark B. Headley, et al.. (2012). Correction: Corrigendum: Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunology. 5(4). 468–468. 1 indexed citations

15.

Lee, Hai-Chon, Mark B. Headley, Yueh–Ming Loo, et al.. (2012). Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection. Journal of Allergy and Clinical Immunology. 130(5). 1187–1196.e5. 166 indexed citations

16.

Siracusa, Mark C., Steven A. Saenz, David A. Hill, et al.. (2011). TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature. 477(7363). 229–233. 411 indexed citations breakdown →

17.

Khan, Omar, Mark B. Headley, Audrey Gérard, et al.. (2011). Regulation of T Cell Priming by Lymphoid Stroma. PLoS ONE. 6(11). e26138–e26138. 71 indexed citations

18.

Headley, Mark B., et al.. (2009). TSLP Conditions the Lung Immune Environment for the Generation of Pathogenic Innate and Antigen-Specific Adaptive Immune Responses. The Journal of Immunology. 182(3). 1641–1647. 86 indexed citations

19.

Headley, Mark B., et al.. (2009). Thymic stromal lymphopoietin and the pathophysiology of atopic disease. Expert Review of Clinical Immunology. 5(5). 547–556. 24 indexed citations

20.

Lee, Hai‐Chon, Mark B. Headley, Masanori Iseki, Koichi Ikuta, & Steven F. Ziegler. (2008). Cutting Edge: Inhibition of NF-κB-Mediated TSLP Expression by Retinoid X Receptor. The Journal of Immunology. 181(8). 5189–5193. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact